The effects of intraoperative administration of glucose on protein and fatty catabolism in diabetic patients

The effects of intraoperative administration of glucose on protein and fatty catabolism in diabetic patients - The impact of intraoperative administration of glucose in diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010914

Enrollment

Registered

2013-06-10

Start date

2013-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

glucose duration: during operation dose: 1.5mg/kg/min blood collection:the start, 6 hours after start, and the end of operation 15ml each no glucose duration: during operation dose: 0 blood c

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: diabetic patients undergoing general anesthesia

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Diabetic patients undergoing general anesthesia will be divided into two groups whether or not glucose is administered intraperatively. The endogenous substances related to glucose metabolism will be measured during surgery.	—

Countries

Japan

Contacts

Public ContactMaiko Hasegawa

Kagoshima University Hospital Anesthesiology

hase-mai@m3.kufm.kagoshima-u.ac.jp0992755430

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026